Approval · Notice of Compliance 8328 · 2006

ACYCLOVIR SODIUM INJECTION: Notice of Compliance 8328

Issued October 18, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 8328
Date: October 18, 2006
Company: Pharmaceutical Partners Of Canada, A Division Of Abraxis Bioscience Inc.
Product type: Prescription Pharmaceutical
Submission: Abbreviated New Drug Submission (ANDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Antiviral agent
Canadian reference product: ZOVIRAX (Glaxo Wellcome Inc.)

Products in this notice

Brand	DIN	Status today
ACYCLOVIR SODIUM INJECTION	02236926	Marketed

Medicinal ingredients

ACYCLOVIR SODIUM 50 MG per ML